Immunologic consequences of chemotherapy for ovarian cancer: impaired responses to the influenza vaccine.

Chu CS, Boyer JD, Jawad A, McDonald K, Rogers WT, Luning Prak ET, Sullivan KE. Immunologic consequences of chemotherapy for ovarian cancer: impaired responses to the influenza vaccine. Vaccine. 2013 Nov 04; 31(46):5435-42.

View in: PubMed

subject areas

Antibodies, Viral
Antineoplastic Agents
Drug Therapy
Female
Hemagglutination Inhibition Tests
Humans
Influenza Vaccines
Influenza, Human
Leukocytes, Mononuclear
Middle Aged
Ovarian Neoplasms
Vaccines, Inactivated

authors with profiles

Kathleen Sullivan, APRN, PMHCNS-BC

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support